title: Celiac Disease in Patients Fulfilling the Rome III Criteria for Irritable Bowel Syndrome Attending Gastroenterology Department of A Tertiary Care Hospital in Bangladesh.
abstract: Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder that substantially affects patients' quality of life and is associated with a considerable drain of health-care resources and economic burden. But some IBS patients may have celiac disease that could be treated by gluten-free diet which will subsequently improve their quality of life. This study was done to see the prevalence of celiac disease among the IBS patients fulfilling Rome III criteria. The present cross-sectional study was conducted in the Department of Gastroenterology at BSMMU, Dhaka from July 2010 to September 2011. A total of 107 patients aged ranging between 16-60 years clinically labeled as IBS and fulfilled Rome III criteria were included as study sample. The test statistics used to analyze the data were descriptive statistics. The mean age of the patients was 31.5±10.3 years and male to female ratio was roughly 6:1. The mean duration of IBS was 32.0±2.1 months. All of the patients had abdominal discomfort or pain in the preceding 6 months and had a history of loose (mushy) or watery stool, 99.1% had pain or discomfort relieved with defaecation. The prevalence of diarrhoea was found in 78.5% and mixed 21.5% of the patients. About 5% of the patients had raised ESR and majority (86.9%) of the patients had normal level of hemoglobin. Ten (9%) of 107 patients were found positive for anti-t TG (IgA). These findings suggest that an around one-tenth of IBS especially diarrhoea predominant patients may have celiac disease who will respond to simple gluten-free diet thus minimizing the morbidity and mortality. So, all clinically diagnosed IBS patients especially diarrhoea predominant cases should be suggested for the screening for celiac disease.
authors.affiliation: Dr Malay Kumar Sur Chowdhury, Assistant Professor, Department of Gastroenterology, Sylhet MAG Osmani Medical College, Sylhet, Bangladesh.
authors.forename: M K
authors.initials: MK
authors.lastname: Chowdhury
authors.forename: R
authors.initials: R
authors.lastname: Chakraborty
authors.forename: S
authors.initials: S
authors.lastname: Gope
authors.forename: M A
authors.initials: MA
authors.lastname: Rahman
authors.forename: A R
authors.initials: AR
authors.lastname: Miah
authors.forename: A S
authors.initials: AS
authors.lastname: Raihan
authors.forename: S
authors.initials: S
authors.lastname: Sarkar
authors.forename: B K
authors.initials: BK
authors.lastname: Paul
authors.forename: K R
authors.initials: KR
authors.lastname: Ferdousi
mesh_terms: D000293:Adolescent; D000328:Adult; D001459:Bangladesh / Q000453:epidemiology; D002446:Celiac Disease / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology; D003430:Cross-Sectional Studies; D003967:Diarrhea / Q000453:epidemiology / Q000209:etiology; D005260:Female; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D062606:Tertiary Care Centers; D055815:Young Adult